Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection

We aimed to explore the influence of ABT on the incidence of MINS, AKI, and overall prognosis among advanced-age HCC patients who underwent hepatectomy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myocardial Injury Acuter Kidney Injury

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients over 65 years with HCC undergoing elective surgery between January 2016 and December 2018

Exclusion criteria

ASA grade V requiring repeat surgery within 1 week losing to follow-up and/or those with >5% missing data

Treatment and study plan

Primary outcomes

the incidence of MINS within postoperative 30 days

Time frame: postoperative day 1-30

Secondary outcomes

overall survival (OS)

Time frame: postoperative day 1-30

the time from the date of surgery to the date of death
postoperative 7-day AKI

Time frame: postoperative day 1-7

Sponsors and collaborators

Lead sponsor

Hao Li

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2025
First posted: Aug 15, 2025
Registry last updated: Aug 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed